Clinical Trials Logo

Filter by:
NCT ID: NCT05812209 Completed - Pain Clinical Trials

Stellate Ganglion Block to Treat Long COVID 19 Case Series

Start date: September 1, 2022
Phase:
Study type: Observational

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

NCT ID: NCT05812105 Completed - Lack of Resources Clinical Trials

Improving the Mobility of Transportation Disadvantaged Older Adults

Start date: October 23, 2020
Phase: N/A
Study type: Interventional

The primary objective of the research was to improve mobility for transportation-disadvantaged older adults by expanding the scope of the existing Healthy Buddy Program, to accommodate an aging Spanish-speaking population in the U.S.

NCT ID: NCT05811988 Completed - Economic Problems Clinical Trials

Cost Assessment of Videolaryngoscopy Compared to Direct Laryncoscopy in a Large Academic Center

Start date: March 31, 2022
Phase:
Study type: Observational

Cost, both direct and indirect, assessment of videolaryngoscopy, specifically the McGrath, compared to direct laryncoscopy in a large academic center.

NCT ID: NCT05811923 Completed - Metabolic Syndrome Clinical Trials

Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine

PX
Start date: December 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the acute impact of ingesting individual and combined dosages of caffeine and paraxanthine in comparison to placebo on changes in resting metabolic rate, perceived levels of affect, and markers of lipolysis.

NCT ID: NCT05811143 Completed - Low Back Pain Clinical Trials

Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.

Start date: September 22, 2020
Phase:
Study type: Observational [Patient Registry]

The specific aims of this proposal are to: Examining the effects of dorsal column stimulation on pain from lumbar spinal stenosis related to lumbar epidural lipomatosis. The primary outcome will be improvement in VAS score of combined back and leg pain at 6 weeks follow-up. Secondary outcomes will include improvement in Visual Analog Scale (VAS) back pain scores, VAS leg pain scores, and Oswestry Disability Index (ODI) , as well as SCS complication rate. The specific aims of this proposal are to: Examining the effects of dorsal column stimulation on pain from lumbar spinal stenosis related to lumbar epidural lipomatosis. The primary outcome will be improvement in VAS score of combined back and leg pain at 6 weeks follow-up. Secondary outcomes will include improvement in VAS back pain scores, VAS leg pain scores, and Oswestry Disability Index, as well as SCS complication rate.

NCT ID: NCT05810714 Completed - Clinical trials for Colorectal Carcinoma

Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in Appalachia

Start date: November 20, 2021
Phase: N/A
Study type: Interventional

This clinical trial compares audio brochures and video brochures to usual care for increasing colorectal cancer (CRC) screening among adults living in Appalachia. Adults living in rural Appalachia experience increased rates of CRC, possibly due to the unique barriers to screening this population faces, such as lower socioeconomic status, limited health literacy, and less access to healthcare. The fecal immunochemical test (FIT) is a common CRC screening technique which allows individuals to complete the test at home and mail the kit back. A limitation of the current process for FIT screening outreach is that the instruction materials are heavy in text and not appropriate for individuals with limited health literacy. The audio and video brochures used in this clinical trial are instruction materials that have been specially designed to be appropriate for individuals of all health literacy levels. Providing these audio and video brochures with the FIT kits may increase CRC screening among adults living in Appalachia, compared to usual care.

NCT ID: NCT05810597 Completed - Healthy Clinical Trials

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

Start date: April 3, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to look at the amount of the study drug, tirzepatide, that gets into the blood stream and how long it takes the body to get rid of it when given using two different devices. The study will also evaluate the safety and tolerability of tirzepatide and information about any side effects experienced will be collected. For each participant, the total duration of the study will be approximately 14 weeks, including screening.

NCT ID: NCT05810558 Completed - Clinical trials for Peri-implant Mucositis

Impact of Glycine Therapy on Peri-implant Mucositis

Start date: June 16, 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine the impact of glycine powder air-abrasive debridement (GPAD) on the microbiology of the tissues surrounding dental implants with health and inflammation (peri-implant mucositis).

NCT ID: NCT05810194 Completed - Clinical trials for Radiation Dermatitis

Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis

Start date: May 1, 2023
Phase:
Study type: Observational

Routinely collected data on radiation-induced skin toxicity from 2010 to 2022 will be retrospectively analyzed. Data will be split into two cohorts: patients that received 1) StrataXRT and 2) standard of care. The incidence of grade ≥ 2 radiation dermatitis, the time to onset of grade ≥ 2 radiation dermatitis, the radiation dose at onset of grade ≥ 2 radiation dermatitis, the incidence of moist desquamation and the number of treatment interruptions will be compared between the cohorts.

NCT ID: NCT05809557 Completed - Oncology Clinical Trials

EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.